Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.
Chauvin C, Levillayer L, Roumier M, Nielly H, Roth C, Karnam A, Bonam SR, Bourgarit A, Dubost C, Bousquet A, Le Burel S, Mestiri R, Sene D, Galland J, Vasse M, Groh M, Le Marchand M, Vassord-Dang C, Gautier JF, Pham-Thi N, Verny C, Pitard B, Planchais C, Mouquet H, Paul R, Simon-Loriere E, Bayry J, Gilardin L, Sakuntabhai A. Chauvin C, et al. Among authors: verny c. iScience. 2023 Mar 17;26(3):106124. doi: 10.1016/j.isci.2023.106124. Epub 2023 Feb 3. iScience. 2023. PMID: 36776936 Free PMC article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Two Cases of ROSAH-Like Syndrome Restricted to the Ophthalmologic Presentation.
Mourozeau L, Pichon V, Bouzidi A, Charif M, Tessarech M, Caignard A, Amati-Bonneau P, Guichet A, Lavigne C, Verny C, Gohier P, Lenaers G. Mourozeau L, et al. Among authors: verny c. Ocul Immunol Inflamm. 2025 Jan 23:1-5. doi: 10.1080/09273948.2025.2453873. Online ahead of print. Ocul Immunol Inflamm. 2025. PMID: 39847428
Unlike other medical conditions, type 2 diabetes is a risk factor for new-onset major depression after COVID-19.
Gasnier M, Lecoq AL, Pham T, Morin L, Radiguer F, Gosset-Grainville E, Quinque M, Alaoui WN, Deflesselle E, Choucha W, Figueiredo S, Zaidan M, Savale L, Montani D, Monnet X, Becquemont L, Corruble E, Colle R; COMEBAC study group. Gasnier M, et al. J Psychosom Res. 2024 Dec;187:111963. doi: 10.1016/j.jpsychores.2024.111963. Epub 2024 Oct 21. J Psychosom Res. 2024. PMID: 39454249
Four- and sixteen-month clinical status of a cohort of patients following hospitalization for COVID-19.
Pham T, Morin L, Savale L, Colle R, Figueiredo S, Harrois A, Gasnier M, Lecoq AL, Meyrignac O, Noel N, Abdo A, Baudry E, Bellin MF, Beurnier A, Choucha W, Corruble E, Dortet L, Gosset E, Hardy-Leger I, Quinque M, Radiguer F, Sportouch S, Verny C, Wyplosz B, Zaidan M, Becquemont L, Montani D, Monnet X. Pham T, et al. Among authors: verny c. Respir Med Res. 2024 Nov;86:101099. doi: 10.1016/j.resmer.2024.101099. Epub 2024 Mar 4. Respir Med Res. 2024. PMID: 38843604 Free article.
Updates in neurogenetics.
Durr A, Verny C. Durr A, et al. Among authors: verny c. Rev Neurol (Paris). 2024 May;180(5):355-356. doi: 10.1016/j.neurol.2024.05.001. Rev Neurol (Paris). 2024. PMID: 38797539 No abstract available.
Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial.
Dinh A, Duran C, Ropers J, Bouchand F, Deconinck L, Matt M, Senard O, Lagrange A, Mellon G, Calin R, Makhloufi S, de Lastours V, Mathieu E, Kahn JE, Rouveix E, Grenet J, Dumoulin J, Chinet T, Pépin M, Delcey V, Diamantis S, Benhamou D, Vitrat V, Dombret MC, Renaud B, Claessens YE, Labarère J, Bedos JP, Aegerter P, Crémieux AC; Pneumonia short treatment (PTC) study group. Dinh A, et al. Clin Microbiol Infect. 2024 Aug;30(8):1020-1028. doi: 10.1016/j.cmi.2024.05.003. Epub 2024 May 9. Clin Microbiol Infect. 2024. PMID: 38734138 Clinical Trial.
Letter to the editor on: prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume.
Bocca C, Kouassi-Nzoughet J, Chao de la Barca JM, Bonneau D, Verny C, Gohier P, Orssaud C, Reynier P. Bocca C, et al. Among authors: verny c. Acta Neuropathol Commun. 2024 Apr 5;12(1):53. doi: 10.1186/s40478-024-01768-1. Acta Neuropathol Commun. 2024. PMID: 38581047 Free PMC article. No abstract available.
180 results